Santhera Pharmaceuticals Holding AG

SANN

Company Profile

  • Business description

    Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives the majority of its revenue from the European Union.

  • Contact

    Hohenrainstrasse 24
    Pratteln4133
    CHE

    T: +41 619068950

    E: [email protected]

    https://www.santhera.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    85

Stocks News & Analysis

stocks

Eagers international foray

Our view on CanadaOne acquisition.
stocks

Tesla: Shares down despite record deliveries

We think the positive third-quarter numbers will be largely offset by a weak fourth quarter.
stocks

ASX listed share dominates their industry

Shares are currently fairly valued with a Wide Moat rating.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,288.1053.600.58%
CAC 408,081.5424.910.31%
DAX 4024,378.8043.76-0.18%
Dow JONES (US)46,803.51283.790.61%
FTSE 1009,491.2563.520.67%
HKSE27,140.92146.20-0.54%
NASDAQ22,785.1758.88-0.26%
Nikkei 22545,769.50832.771.85%
NZX 50 Index13,514.0962.330.46%
S&P 5006,720.344.990.07%
S&P/ASX 2008,987.4050.800.57%
SSE Composite Index3,882.7820.250.52%

Market Movers